World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
15330
World Ranking
3535
National Ranking
1394

Lisa M. Frenkel publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Lisa M. Frenkel sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 240 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Lisa M. Frenkel D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa M. Frenkel sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Lisa M. Frenkel is affiliated with the University of Washington in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a strong focus on infectious diseases, virology, epidemiology, emergency medicine, and molecular biology.

The scientist's work concentrates heavily on HIV-related research and treatment. Specific topics include HIV/AIDS research and interventions, drug development and treatment for HIV/AIDS, and HIV-related health complications and treatments. Additionally, they have contributed to research related to SARS-CoV-2 and COVID-19, covering detection, testing, and clinical research studies.

Frequent co-authors collaborating with Lisa M. Frenkel include:

  • Ingrid A. Beck
  • Nuttada Panpradist
  • Barry R. Lutz
  • Ceejay L. Boyce
  • Daisy Ko

The scientist has published extensively in venues such as:

  • PLoS ONE
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet HIV
  • Viruses
  • Cell Reports Medicine

Notable recent papers include:

  • "Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial," 2021, The Lancet
  • "A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir," 2021, Cell Reports Medicine
  • "Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19," 2021, Cell Reports Medicine
  • "Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component," 2021, JAIDS Journal of Acquired Immune Deficiency Syndromes
  • "Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial," 2020, The Lancet HIV

Lisa M. Frenkel was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2017.

Best Publications

  • Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

    Jared M. Baeten;Deborah Donnell;Deborah Donnell;Patrick Ndase;Nelly R. Mugo;Nelly R. Mugo

  • Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

    Thor A. Wagner;Sherry McLaughlin;Sherry McLaughlin;Kavita Garg;Charles Y. K. Cheung

  • Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era

    David W. Kimberlin;Chin-Yu Lin;Richard F. Jacobs;Dwight A. Powell

  • A population-based study of primary human herpesvirus 6 infection.

    Danielle M. Zerr;Amalia S. Meier;Stacy S. Selke;Lisa M. Frenkel

  • HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

    Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

  • Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus Infection

    A. Willoughby;L. M. Mofenson;R. Nugent;J. Moye

  • Oral acyclovir suppression and neurodevelopment after neonatal herpes.

    David W. Kimberlin;Richard J. Whitley;Wen Wan;Dwight A. Powell

  • Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus

    Nicole H. Tobin;Gerald H. Learn;Sarah E. Holte;Yang Wang

  • Itraconazole treatment of phaeohyphomycosis.

    Patricia Kay Sharkey;John R. Graybill;Michael G. Rinaldi;David A. Stevens

  • Treatment of cytomegalovirus retinopathy with ganciclovir.

    Gary N. Holland;Gary N. Holland;Yossi Sidikaro;Yossi Sidikaro;Allan E. Kreiger;Allan E. Kreiger;David Hardy

  • Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

    Jane Hitti;Lisa M. Frenkel;Alice M. Stek;Sharon A. Nachman

  • Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric AIDS Clinical Trials Group Protocol 076

    P. Scott Eastman;David E. Shapiro;Robert W. Coombs;Lisa M. Frenkel

  • The management of pregnancies complicated by genital infections with herpes simplex virus.

    Charles G. Prober;Lawrence Corey;Zane A. Brown;Paul A. Hensleigh

  • Simple, Sensitive, and Specific Detection of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried Blood Samples for Diagnosis in Infants in the Field

    Ingrid A. Beck;Kathryn D. Drennan;Ann J. Melvin;Kathey M. Mohan

  • First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

    Linda Harrison;Abdel Babiker;Hannah Castro;Alexandra Compagnucci

  • Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency

    Elias K. Halvas;Grace M. Aldrovandi;Peter Balfe;Ingrid A. Beck

  • Pharmacokinetics of acyclovir in the term human pregnancy and neonate.

    Lisa M. Frenkel;Zane A. Brown;Yvonne J. Bryson;Lawrence Corey

  • Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

    Shahin Lockman;Shahin Lockman;Sean S Brummel;Lauren Ziemba;Lynda Stranix-Chibanda

  • Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

    Gary N. Holland;Michael J. Sakamoto;David Hardy;Yossi Sidikaro

  • Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

    Jared M. Baeten;Deborah Donnell;Deborah Donnell;Nelly R. Mugo;Nelly R. Mugo;Patrick Ndase

  • Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors.

    Ann J. Melvin;Kathleen M. Mohan;Laura A. Manns Arcuino;Reva E. Edelstein

  • Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis

    Dara A. Lehman;Jared M. Baeten;Connor O. McCoy;Julie F. Weis

Frequent Co-Authors

Robert W. Coombs
Robert W. Coombs University of Washington
James I. Mullins
James I. Mullins University of Washington
Deborah Donnell
Deborah Donnell Fred Hutchinson Cancer Research Center
Jared M. Baeten
Jared M. Baeten University of Washington
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Grace John-Stewart
Grace John-Stewart University of Washington
Allan R. Ronald
Allan R. Ronald University of Manitoba
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Gerald H. Learn
Gerald H. Learn University of Pennsylvania
Connie Celum
Connie Celum University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities. Programs like public health often complement microbiology studies. If you’re considering this route, checking out the easy mph online programs can help you find flexible and accessible options to advance your education.

Career pathways tied to microbiology include specialized roles such as a child life specialist salary, which merges healthcare knowledge with patient support, or a functional medicine nurse practitioner salary, a growing field focusing on holistic health practices.

It’s also encouraging to know that online degree programs provide second chances for many. If you have a criminal record and are worried about your educational prospects, you can explore what is the best degree for a convicted felon to find suitable and supportive degree pathways.

Overall, the availability of online degrees related to microbiology offers flexibility and diverse options for learners aiming to build rewarding careers in health sciences and beyond.

Best Scientists Citing Lisa M. Frenkel

Trending Scientists

Recently Published Articles